Cerebrospinal fluid neurofilament light chain and tau protein were found as mortality biomarkers in parkinsonism, including PSP, but it was unable to tell the difference among each specific parkinsonian type (19). This evidence concerns the gene NEFL and supranuclear palsy, progressive, 1.